Mitochondrial DNA Replication and Disease: A Historical Perspective on Molecular Insights and Therapeutic Advances.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing molecular mechanisms and therapeutic concepts without systematic review methodology or primary human data.
PubMed 41226312 · doi:10.3390/ijms262110275
What was done
This narrative review summarizes molecular mechanisms governing mitochondrial DNA replication, focusing on core replisome components including DNA polymerase gamma, Twinkle helicase, and mitochondrial single-stranded DNA binding protein, along with related nucleotide metabolism pathways, associated mitochondrial disorders, and historical therapeutic strategies.
What was found
The abstract provides a descriptive overview of the replication machinery and the genetic basis of mitochondrial diseases resulting from point mutations, deletions, or depletion. No empirical measurements, quantitative findings, or clinical outcome statistics are reported.
Why it matters
The review synthesizes fundamental molecular biology of the human mitochondrial replisome with the clinical understanding of mitochondrial pathologies and emerging therapeutic avenues.
Limits
As a broad narrative review, the article does not employ systematic review methods, meta-analytic pooling, or new empirical data. Specific treatment efficacies and clinical outcomes are not quantitatively evaluated in the abstract.
Cited by
- supports Mitochondria contain their own DNA, and mutations in this genetic code can disrupt ATP synthesis, leading to mitochondrial diseases.